Statement about previous postings and presentations: due to the regulatory implications of the present study, the main results on tNSAIDs were presented to the Committee on Safety of Medicines for Human Use of the Spanish Agency for Medicines and Medical Devices (AEMPS). Also, this information was shared, under strict confidential measures, with the members of the Pharmacovigilance and Risk Assessment Committee of the European Medicines Agency.
Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study†
Version of Record online: 1 APR 2014
Copyright © 2014 John Wiley & Sons, Ltd.
Pharmacoepidemiology and Drug Safety
Volume 23, Issue 11, pages 1128–1138, November 2014
How to Cite
2014), Risk of nonfatal acute myocardial infarction associated with non-steroidal antiinflammatory drugs, non-narcotic analgesics and other drugs used in osteoarthritis: a nested case-control study, Pharmacoepidemiol Drug Saf, 23; pages 1128–1138, doi: 10.1002/pds.3617, , , , , , and (
- Issue online: 10 NOV 2014
- Version of Record online: 1 APR 2014
- Manuscript Accepted: 27 FEB 2014
- Manuscript Revised: 24 FEB 2014
- Manuscript Received: 26 NOV 2013
- Fondo de Investigación Sanitaria—Ministerio de Ciencia e Innovación. Grant Number: PI071064
|pds3617-sup-0001-documentS1.docx||Word 2007 document||50K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.